Coastal Bridge Advisors LLC Has $424,000 Stock Holdings in Kenvue Inc. $KVUE

Coastal Bridge Advisors LLC decreased its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 68.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 26,146 shares of the company’s stock after selling 57,988 shares during the quarter. Coastal Bridge Advisors LLC’s holdings in Kenvue were worth $424,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of KVUE. NBT Bank N A NY grew its holdings in Kenvue by 180.3% during the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock valued at $25,000 after purchasing an additional 1,006 shares during the last quarter. Salomon & Ludwin LLC bought a new position in shares of Kenvue in the third quarter worth about $25,000. Trust Co. of Vermont increased its position in Kenvue by 266.8% in the 2nd quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock worth $33,000 after buying an additional 1,150 shares during the period. New England Capital Financial Advisors LLC boosted its position in shares of Kenvue by 81.4% in the third quarter. New England Capital Financial Advisors LLC now owns 2,563 shares of the company’s stock valued at $42,000 after acquiring an additional 1,150 shares during the period. Finally, Future Financial Wealth Managment LLC acquired a new stake in Kenvue in the 3rd quarter worth $49,000. 97.64% of the stock is currently owned by institutional investors.

Insider Transactions at Kenvue

In other news, Director Jeffrey C. Smith acquired 3,200,000 shares of the stock in a transaction on Friday, December 12th. The stock was acquired at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the completion of the transaction, the director directly owned 27,307,632 shares in the company, valued at approximately $474,333,567.84. This trade represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through the SEC website. 1.68% of the stock is owned by company insiders.

Kenvue Stock Performance

Shares of NYSE KVUE opened at $17.41 on Friday. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.69. The firm has a market cap of $33.36 billion, a price-to-earnings ratio of 23.21 and a beta of 0.60. The stock’s fifty day moving average price is $17.16 and its two-hundred day moving average price is $18.04. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.28 EPS for the quarter, beating the consensus estimate of $0.27 by $0.01. Kenvue had a net margin of 9.55% and a return on equity of 20.02%. The business had revenue of $3.76 billion for the quarter, compared to the consensus estimate of $3.83 billion. During the same period in the prior year, the company posted $0.28 earnings per share. Kenvue’s revenue was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, equities analysts forecast that Kenvue Inc. will post 1.14 EPS for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th will be given a dividend of $0.2075 per share. The ex-dividend date is Wednesday, February 11th. This represents a $0.83 annualized dividend and a dividend yield of 4.8%. Kenvue’s dividend payout ratio (DPR) is currently 110.67%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. UBS Group cut their price objective on Kenvue from $23.00 to $17.00 and set a “neutral” rating for the company in a report on Wednesday, October 8th. JPMorgan Chase & Co. reduced their target price on shares of Kenvue from $24.00 to $21.00 and set an “overweight” rating on the stock in a research note on Friday, October 10th. Barclays increased their price objective on shares of Kenvue from $17.00 to $18.00 and gave the company an “equal weight” rating in a report on Monday, November 10th. Edward Jones cut shares of Kenvue from a “strong-buy” rating to a “hold” rating in a research note on Monday, November 3rd. Finally, Deutsche Bank Aktiengesellschaft set a $18.00 target price on shares of Kenvue in a research report on Friday, October 24th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and thirteen have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $19.90.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.